People / Staff

Pablo Menéndez Buján

Search publications

Publications

  • Ahlgren, L, Pilheden, M, Sturesson, H, Song, GC, Walsh, MP, Yang, MJ, Maillard, M, Zhao, HB, Cheng, ZS, Singh, V, Castor, A, Pronk, CJ, Marquart, HV, Lausen, B, Schneider, P, Barbany, G, Tamm, KP, Abrahamsson, J, Lohi, O, Fogelstrand, L, Menendez, P, Pieters, R, Zhang, JH, Lindkvist-Petersson, K, Yang, JJ, Gruber, TA, Stam, RW, Ma, J and Hagström-Andersson, AK.

    The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

    Nature Communications . 16(1): 8964-8964. Number of citations: 1

    [doi:10.1038/s41467-025-64190-8]

  • Pérez-Amill L, Armand-Ugón M, Val-Casals M, Martín-Herreros B, Álamo JR, Peña S, Frigola G, Altuna A, Santos C, Guijarro F, Minguela A, Bataller À, Casanovas-Albertí B, Uribe-Herranz M, Navarro I, Guerreiro M, Sánchez-Martínez D, Tirado N, Velasco-Hernandez T, Menéndez P, Martínez A, Rovira M, Colomer D, González-Navarro EA, Esteve J, Urbano-Ispizua Á, Montesinos P, Delgado J, Juan M and Klein-González N.

    A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias.

    LEUKEMIA . 39(10): 2432-2441.

    [doi:10.1038/s41375-025-02705-4]

  • Palma, LG, Kartha, GM, Maqueda, M, Barrero, M, Canton, E, Iglesias, A, González, J, Herrero-Molinero, P, Torres-Ruiz, R, Payer, B, Bueno, C, Menéndez, P, Espinosa, L and Bigas, A.

    An unbiased genomewide screen uncovers 7 genes that drive hematopoietic stem cell fate from mouse embryonic stem cells.

    BLOOD . 146(3): 328-340. Number of citations: 2

    [doi:10.1182/blood.2024027742]

  • Zugasti I, Espinosa-Aroca L, Fidyt K, Mulens-Arias V, Diaz-Beya M, Juan-Otero M, Urbano-Ispizua Á, Esteve J, Velasco-Hernandez T and Menéndez P.

    CAR-T cell therapy for cancer: current challenges and future directions.

    Signal Transduction and Targeted Therapy . 10(1): 210-210. Number of citations: 117

    [doi:10.1038/s41392-025-02269-w]

  • Tirado N, Fidyt K, Mansilla MJ, Garcia-Perez A, Martínez-Moreno A, Vinyoles M, Alcain J, García-Peydró M, Roca-Ho H, Fernandez-Fuentes N, Guerrero-Murillo M, Falgàs A, Velasco-Hernandez T, Bueno C, Panelli P, Mulens-Arias V, Apostolov A, Engel P, González EA, Vick B, Jeremias I, Caye-Eude A, Baruchel A, Cavé H, Genescà E, Ribera J, Díaz-Beyá M, Martínez-Sánchez MV, Fuster JL, Escudero López A, Minguillón J, Pérez-Martínez A, Ramírez-Orellana M, Torrebadell-Burriel M, Díaz VM, Toribio ML, Sánchez-Martínez D and Menéndez P.

    CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

    Journal of Hematology & Oncology . 18(1): 69-69. Number of citations: 7

    [doi:10.1186/s13045-025-01715-0]

  • Almaghrabi, R, Alyahyawi, Y, Keane, P, Mian, SA, Habel, K, Atkinson, A, Ward, C, Bayley, R, Sargas, C, Menendez, P, Murphy, GJ, Sobahy, T, Baghdadi, MA, Flemban, AF, Kabrah, SM, Torres-Ruiz, R, Papapetrou, EP, Akerman, I, Raghavan, M, Barragan, E, Bonnet, D, Bonifer, C and Garcia, P.

    A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression.

    Nature Communications . 16(1): 5489-5489. Number of citations: 1

    [doi:10.1038/s41467-025-60192-8]

  • Baulenas-Farrés M, Paco-Mercader S, Marino F, Mohr J, Panisello C, Balaguer-Lluna L, Aschero MR, Cuadrado-Vilanova M, Resa-Parés C, Rodriguez E, Márquez-Pereira JM, Menéndez P, Jou-Munoz C, Benítez R, Benitez-Ribas D, Lavarino C, Mora J and Carcaboso AM.

    Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma.

    Neuro-Oncology Advances . 7(1): . Number of citations: 1

    [doi:10.1093/noajnl/vdaf132]

  • Marhelava, K, Fidyt, K, Pepek, M, Krawczyk, M, Forcados, C, Malinowska, A, Swiderska, B, Fernandez-Fuentes, N, Czerwik, N, Baranowska, I, Krzywdzinska, A, Sedek, L, Slota, L, Perkowski, B, Villatoro, A, Leray, T, Lech-Maranda, E, Menendez, P, Inderberg, EM, Wälchli, S, Winiarska, M and Firczuk, M.

    LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

    LEUKEMIA . 39(6): 1395-1411. Number of citations: 3

    [doi:10.1038/s41375-025-02580-z]

  • Falgàs A, Lázaro-Gorines R, Zanetti SR, Rubio-Pérez L, Martinez-Moreno A, Vinyoles M, Guerrero-Murillo M, Fernandez-Fuentes N, Roca-Ho H, Tirado N, Panisello C, Velasco-Hernandez T, Mayado A, Pérez-Pons A, Genesca E, Ribera JM, Ribera J, Camós-Guijosa M, Ramírez-Orellana M, Anguita E, Ballerini P, Fuster JL, Juan M, González-Navarro EAA, Locatelli F, Stam RWW, Querol S, Velasco P, Ortiz-Maldonado V, Martínez-Cibrian N, Delgado J, Orfao A, Alvarez-Vallina L, Bueno C and Menendez P.

    A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

    BLOOD . 145(22): 2599-2613. Number of citations: 9

    [doi:10.1182/blood.2024025440]

  • Arroyo-Ródenas, J, Falgas, A, Díez-Alonso, L, Martinez-Moreno, A, Roca-Ho, H, Gil-Etayo, FJ, Pérez-Pons, A, Aguilar-Sopeña, O, Velasco-Sidro, M, Gómez-Rosel, M, Jiménez-Matías, B, Muñoz-Sánchez, G, Pacheco, Y, Bravo-Martín, C, Ramírez-Fernández, A, Jiménez-Reinoso, A, González-Navarro, EA, Juan-Otero M, Orfao, A, Blanco, B, Roda-Navarro, P, Bueno, C, Menéndez, P and Alvarez-Vallina, L.

    CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression.

    Journal for ImmunoTherapy of Cancer . 13(4): . Number of citations: 5

    [doi:10.1136/jitc-2024-009048]